title: [Should new generation antiepileptic drugs be prescribed as first-line treatment of newly diagnosed epilepsy in adolescents and adults?].
authors: Service de Neurologie Fonctionnelle et d'Epileptologie, Hôpital Neurologique, Lyon. ryvlin@cermep.fr
authors: P
authors: P
authors: Ryvlin
authors: P
authors: P
authors: Kahane
authors: F
authors: F
authors: Semah
authors: E
authors: E
authors: Hirsch
authors: A
authors: A
authors: Arzimanoglou
authors: P
authors: P
authors: Thomas
mesh_terms: D000293:Adolescent; D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects / Q000191:economics / Q000493:pharmacokinetics / Q000627:therapeutic use*; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects; D004347:Drug Interactions; D004790:Enzyme Induction; D004827:Epilepsy / Q000188:drug therapy* / Q000191:economics / Q000378:metabolism; D005260:Female; D006801:Humans; D008297:Male; D011247:Pregnancy; D016032:Randomized Controlled Trials as Topic; D013723:Teratogens
chemical_list: D000927:Anticonvulsants; D003278:Contraceptives, Oral, Hormonal; D013723:Teratogens